- Category
- Small (2023-24)
- Udyam number
- UDYAM-KR-23-0000213

About Larson Pharma Private Limited
Data last updated:
Larson Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 April 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2006PTC049977. Its GSTIN is 29AAJCS8965Q1Z0 (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.45 Cr. It was formerly known as Larson Pharma Limited and Sasank Biotech Limited. It is led by directors Yeturu Sita Mahalakshmi and Yeturu Srinivasa Reddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.93 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹79.01 Lakh (net margin 2.3%) and EBITDA of ₹2.61 Cr (EBITDA margin 7.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 26% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Larson Pharma. As per MCA filings, the company has open charges of ₹13.64 Cr and satisfied charges of ₹5.7 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022. Its 5 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Mancare Pharmaceuticals Private Limited with revenue of ₹34.15 Cr.
Larson Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-23-0000213). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website larsonpharma.in.
Company details
Name history
Larson Pharma has undergone 2 name changes throughout its history. The company was previously known as Larson Pharma Limited, and Sasank Biotech Limited. The current legal name is Larson Pharma Private Limited.
| Company Name | Status |
|---|---|
| Larson Pharma Private Limited | Current |
| Larson Pharma Limited | Previous |
| Sasank Biotech Limited | Previous |
CIN history
Larson Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24233TG2006PTC049977, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2006PTC049977 | Current |
| U24239AP2006PLC049977 | Previous |
| U24233TG2006PLC049977 | Previous |
| U24239TG2006PLC049977 | Previous |
Recognitions & Rankings of Larson Pharma
Contact details
Larson Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is larsonpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 187 Mig Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Larson Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Larson Pharma operates one associated brand: Larson Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing and supplying a range of pharmaceutical products and ingredients. | larsonpharma.in |
Business activity
The main business activity of Larson Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Larson Pharma Private Limited, buy the company report.
Financials of Larson Pharma Private Limited
FY 2025 filings availableLarson Pharma Private Limited reported revenue of ₹33.93 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 23% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.7% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Larson Pharma Private Limited, buy the company report.
Board of directors of Larson Pharma Private Limited
Larson Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yeturu Sita Mahalakshmi Also directs: Shivani Organics Private Limited, Ysr Pharma Private Limited | Director | 20 Dec 2011 | 14 Years 10 Months | Current |
| Yeturu Srinivasa Reddy | Director | 20 Apr 2006 | 20 Years 6 Months | Current |
Peer comparison
Larson Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mancare Pharmaceuticals Private Limited | ₹34.15 Cr (FY 2025) | -1.0% | Vasai, Maharashtra, India | |||
| Maps Laboratories Private Limited | ₹34.03 Cr (FY 2024) | -25.0% | Rajkot, Gujarat, India | |||
| Larson Pharma Private Limitedthis company | ₹33.93 Cr (FY 2025) | ₹79.01 Lakh | 2.3% | 23.0% | 21 | Hyderabad, Telangana, India |
| Supal Pharmacare Limited | ₹33.91 Cr (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Vijaya Sai Laboratories India Private Limited | ₹33.9 Cr (FY 2025) | -12.0% | Telangana, India | |||
| Franco-Indian Remedies Private Limited | ₹33.65 Cr (FY 2024) | -8.0% | Tamil Nadu, India |
To see the full peer comparison of Larson Pharma Private Limited, buy the company report.
Auditor
Larson Pharma Private Limited is audited by C V RAMANA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C V RAMANA & ASSOCIATES | FY 2022 | 009188S |
Shareholding
The shareholding of Larson Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Larson Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2024 | 100922525 | Others | ₹1.71 Cr | Open | |
| 01 Jul 2022 | 100594728 | Hdfc Bank Limited | ₹14.57 Lakh | Open | |
| 12 May 2022 | 100572354 | Axis Bank Limited | ₹11.65 Cr | Open | |
| 18 Apr 2022 | 100572119 | Hdfc Bank Limited | ₹13.58 Lakh | Open | |
| 16 Jul 2021 | 100461422 | Canara Bank | ₹1.95 Cr | Satisfied |
To see the full charge records of Larson Pharma Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Larson Pharma Private Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Rights issue | ₹3.69 Cr | Investors: 3 individuals |
| Mar 2013 | Funding round | ₹2.71 Cr | Investors: 4 individuals |
| Dec 2011 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Larson Pharma Private Limited has 1 court case on record: 1 filed by Larson Pharma. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against M/S Power Care Solutions Pvt Ltd. Rep by Kannan Thiyagrajan | Pending |
To see the full case history of Larson Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Larson Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Larson Pharma Private Limited has a workforce of 21 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 21 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Larson Pharma Private Limited, buy the company report.
GST
Larson Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCS8965Q1Z0 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Larson Pharma Private Limited, buy the company report.
Recent activity
Larson Pharma Private Limited has 5 board changes on record since 2006: 2 appointments and 3 cessations. The latest: Chandra Obulreddy Ramireddy ceased to be Director on 17 Mar 2021.
6 earlier events are in the company report.
Frequently asked questions
Larson Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 April 2006 (20+ years old) and is registered under CIN U24233TG2006PTC049977.
Larson Pharma has 2 current directors:
- Yeturu Sita Mahalakshmi - Director
- Yeturu Srinivasa Reddy - Director
The latest financial statements of Larson Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Larson Pharma is 29AAJCS8965Q1Z0, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Larson Pharma is U24233TG2006PTC049977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Larson Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Larson Pharma was incorporated on 20 April 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Larson Pharma has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹2.71 Cr; the latest was in March 2022.
The peers of Larson Pharma by revenue are Mancare Pharmaceuticals Private Limited, Maps Laboratories Private Limited, Supal Pharmacare Limited, Vijaya Sai Laboratories India Private Limited, Franco-Indian Remedies Private Limited, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandra Obulreddy Ramireddy ceased to be Director on 17 Mar 2021. Yeturu Sita Mahalakshmi ceased to be Additional Director on 29 Sep 2012. Gangi Reddy Narravula ceased to be Director on 20 Dec 2011. Larson Pharma has 5 board changes on record in total.
Yes, Larson Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KR-23-0000213).

